Underwriter’s Warrant. The Underwriter’s Warrant, substantially in the form of Exhibit E hereto, executed by the officers of the Company, delivered to the Underwriter on or before the date hereof, shall be in full force and effect on the Closing Date or any Additional Closing Date, as the case may be.
Underwriter’s Warrant. As additional compensation for the Underwriter’s services, the Company shall issue to the Underwriter or its designees at the closing of this offering warrants (the “Underwriter’s Warrant”) to purchase that number of Ordinary Shares equal to three percent (3.0%) of the aggregate number of Ordinary Shares sold in this offering. The Underwriter’s Warrant will be exercisable at any time and from time to time, in whole or in part, during the period commencing six months from the commencement of sales of the Firm Shares in the public offering and ending four years and six months thereafter, at a price per share equal to 125.0% of the Public Offering Price per Ordinary Share at the offering. The Underwriter’s Warrant and the Ordinary Shares issuable upon exercise thereof are sometimes hereinafter referred to collectively as the “Underwriter’s Securities” (collectively, together with the Shares, the “Securities”). The Underwriter understands and agrees that there are restrictions pursuant to FINRA Rule 5110 against transferring the Underwriter’s Warrant and the underlying Ordinary Shares during the 180-day period after the commencement of sales of the public offering and by its acceptance thereof shall agree that it and its respective designees, if any, will not, sell, transfer, assign, pledge or hypothecate the Underwriter’s Securities, or any portion thereof, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities for a period of 180 days following the commencement of sales of the public offering to anyone other than (A) the Underwriter or a selected dealer in connection with the offering, or (B) a bona fide officer or partner of the Underwriter; and only if any such transferee agrees to the foregoing lock-up restrictions. Delivery of the executed Underwriter’s Warrant shall be made on the Closing Date and the Underwriter’s Warrant shall be issued in the name or names and in such authorized denominations as the Underwriter may request.
Underwriter’s Warrant. The Company hereby agrees to issue to the Representative (and/or its designees) on the applicable Closing Date and Option Closing Date (if applicable), Warrants, substantially in the form of Exhibit A attached hereto, to purchase such number of shares of Common Stock equal to six percent (6.0%) of the Offered Securities sold by the Company (the “Underwriter’s Warrant”), including any shares of Common Stock issued pursuant to the exercise of Over-allotment Option. The Underwriter’s Warrant shall be exercisable, in whole or in part, commencing six months from issuance and expiring on the fifth-year anniversary of the commencement of sale of the Offering at an initial exercise price of $[●] per shares of Common Stock, which is equal to one hundred and ten percent (110%) of the initial public offering price of a Firm Share.
Underwriter’s Warrant. The Company hereby agrees to issue to the Underwriter (and/or its designees) on the applicable Closing Date, Warrants to purchase such number of Shares equal to six percent (6%) of the Firm Shares issued at the Closing (for the avoidance of doubt, not including the Additional Shares) (the “Underwriter’s Warrant”). The Underwriter’s Warrant shall be exercisable, in whole or in part, commencing anytime from the date of issuance and expiring on the fifth-year anniversary of the effective date of the Offering at an initial exercise price of $[●] per Ordinary Share, which is equal to one hundred ten percent (110%) of the initial public offering price of a Firm Share. The Underwriter’s Warrant and the Ordinary Shares issuable upon exercise of the Underwriter’s Warrant are hereinafter referred to collectively as the “Underwriter’s Securities.” The Firm Shares, the Additional Shares and the Underwriter’s Securities are hereinafter referred to collectively as the “Securities.”
Underwriter’s Warrant. The Company hereby agrees to issue to the Underwriters on the applicable Closing Date as compensation, Warrants, substantially in the form of Exhibit B attached hereto, to purchase such number of Ordinary Shares equal to six percent (6%) of the Offering (the “Underwriters’ Warrant”). The Underwriters’ Warrant shall be exercisable, in whole or in part, commencing anytime from the date of issuance and expiring on the fifth-year anniversary of the commencement of sales in the Offering at an initial exercise price of $[●]1per share, which is equal to one hundred and twenty-five percent (125%) of the initial public offering price of a Firm Share. 1 125% of the Offering Price
Underwriter’s Warrant. The Company hereby agrees to issue to the Underwriter (and/or its designees) on a Closing Date, as defined in Section 3(c) herein, a warrant to purchase a number of Ordinary Shares equal to seven percent (7%) of the Ordinary Shares sold on such Closing Date (“Underwriter’s Warrant”). The Underwriter’s Warrant, in the form attached hereto as Exhibit A, shall be exercisable, in whole or in part, commencing on the date of issuance and expiring on the five-year anniversary from the date that the Commission (as defined herein) declared the Registration Statement (as defined herein) effective (the “Effective Date”) at an initial exercise price equal to 110% of the Per Share Price (as defined below) of the Securities. The Underwriter’s Warrant shall include a “cashless” exercise feature. The Underwriter understands and agrees that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the Underwriter’s Warrant and the underlying Ordinary Shares during the one hundred eighty (180) days after the Effective Date and by its acceptance thereof shall agree that it will not sell, transfer, assign, pledge or hypothecate the Underwriter’s Warrant, or any portion thereof, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities for a period of one hundred eighty (180) days following the Effective Date to anyone other than the circumstances listed under FINRA Rule 5110(g)(2). Delivery of the Underwriter’s Warrant shall be made on a Closing Date and shall be issued in the name or names and in such authorized denominations as the Underwriter may request.
Underwriter’s Warrant. On the First Closing Date, the Company will issue to you, for total consideration of $5.00 and upon the terms and conditions set forth in the form of Underwriter's Warrant annexed as an exhibit to the Registration Statement, an Underwriter's Warrant to purchase, in the aggregate, one Share for each ten Firm Shares sold in the Offering. In the event of conflict in the terms of this Agreement and the Underwriter's Warrant, the language of the Underwriter's Warrant shall control.
Underwriter’s Warrant. On or prior to the Closing Date, the Company shall deliver to the Representatives warrants (the "Underwriter's Warrants"), at an aggregate purchase price of $100, to purchase Shares equal to 10% of the Firm Shares sold in the Offering, which Underwriter's Warrants shall be exercisable for a per Share exercise price equal to 120% of the per Share public offering price of the Firm Shares.
Underwriter’s Warrant. The Company hereby agrees to issue to the Underwriter (and/or its designees) on the applicable Closing Date and/or Option Closing Date, as the case may be, Warrants to purchase such number of Shares equal to five (5%) of the Offered Shares issued at the Closing (the “Underwriter’s Warrant”). The Underwriter’s Warrant shall be exercisable, in whole or in part, commencing 180 days after from the commencement of sales of the Offering and expiring on the fifth-year anniversary thereafter at an initial exercise price of $4.80 per Share, which is equal to one hundred twenty percent (120%) of the initial public offering price of a Firm Share. The Underwriter’s Warrant and the shares of Common Stock issuable upon exercise of the Underwriter’s Warrant are hereinafter referred to collectively as the “Underwriter’s Warrant Securities.” The Offered Shares and the Underwriter’s Warrant Securities are collectively referred to as the “Securities.”
Underwriter’s Warrant. On or before each Closing Date, the Underwriter shall have received executed copies of the Underwriter’s Warrant.
